Company news
Anagenics Limited (ASX:AN1) news
Every Anagenics Limited press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
AN1 FY26-Appendix-4E-
August 28, 2026
Appendix 4C & Activity Report for Q4 FY2026
July 29, 2026
AN1 - Appendix 4C & Activity Report for Q3 FY2026
April 27, 2026
Appendix 4D 1H FY26 DEC 2025
February 24, 2026
Anagenics - 1H FY26 Result Highlights
February 24, 2026
Appendix 4C & Activity Report for Q2 FY2026
January 29, 2026
Placement of Shares
December 9, 2025
Trading Halt
December 7, 2025
Appendix 4C & Activity Report for Q1 FY2026
October 30, 2025
AN1 - FY 2025 Presentation
August 28, 2025
AN1 FY25-Appendix-4E-Preliminary-Final-Report
August 27, 2025
Activity Report & Appendix 4C Q4 FY2025
July 28, 2025
YSB Bouf Haircare Continues Strong Performance
June 27, 2025
York Street Brands Product Launch
June 4, 2025
AN1 - 3Q25 Presentation
May 4, 2025
Reinstatement to Quotation
May 2, 2025
AN1 - Pre-reinstatement Disclosure
May 2, 2025
AN1 3Q25 Activity Report
May 1, 2025
Appendix 4C Cash Flow Report
May 1, 2025
Long Term Suspended Entities
April 9, 2025
AN1 - 1H25 Update
February 27, 2025
AN1 - Appendix 4D 1H FY2025
February 27, 2025
Update on 2Q25 Activity Report
February 10, 2025
Q2 F25 Activity Statement and Appendix 4C
January 31, 2025
Restructuring Update & Resignation of Director
October 31, 2024
Q1 F25 Activity Statement and Appendix 4C
October 31, 2024
Anagenics : 2024 Anagenics Annual Report
October 3, 2024
Market Update
October 2, 2024
Suspension from Official Quotation
September 3, 2024
Pause in Trading
September 2, 2024
FY24 4E Presentation
August 30, 2024
Appendix 4E and Preliminary Final Report
August 30, 2024
Company Update License Partnership Announcement
July 23, 2024
Appendix 4C Cash Flow & Activities Report
July 23, 2024
Midkine Antibody Licensing Deal
May 24, 2024
Quarterly Activities/Appendix 4C Cash Flow Report
April 28, 2024
Organisational Changes
March 7, 2024
H1 FY24 Results and Corporate Update
February 26, 2024
Appendix 4D and Half Year Report
February 26, 2024
Investor Presentation
February 6, 2024
Completion of Placement
February 6, 2024
Appendix 4C and Quarterly Activity Report
October 30, 2023
Business Update
October 1, 2023
Acquisition of Face MediGroup Presentation
August 22, 2023
Anagenics to Acquire Face MediGroup
August 22, 2023
FY23 Financial Performance and Business Update
June 27, 2023
CEO Appointment
March 28, 2023
Results of Institutional Entitlement Offer
February 15, 2023
Entitlement Offer and Company Update
February 13, 2023
Corporate Update and Acquisition
December 8, 2022